Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 118 of 3330
Next
>>
>
2926 to 2950 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	0.0128	uM	10817.143	0.9982	0.9978	1.5734
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	0.064	uM	10817.143	0.9618	0.9511	1.5734
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	0.32	uM	10817.143	0.9649	0.9551	1.5734
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	1.6	uM	10817.143	0.9416	0.9249	1.5734
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	8	uM	10817.143	0.6647	0.5428	1.5734
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	40	uM	10817.143	0.5419	0.3549	1.5734
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	200	uM	10817.143	0.4313	0.1719	1.5734
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	1000	uM	10817.143	0.1716	-0.3476	1.5734
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	5000	uM	10817.143	0.0221	-0.8227	1.5734
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	0.0128	uM	12365.143	0.9753	0.9791	2.3865
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	0.064	uM	12365.143	0.8742	0.8905	2.3865
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	0.32	uM	12365.143	0.9231	0.9340	2.3865
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	1.6	uM	12365.143	0.8213	0.8416	2.3865
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	8	uM	12365.143	0.6038	0.6189	2.3865
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	40	uM	12365.143	0.3797	0.3329	2.3865
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	200	uM	12365.143	0.2767	0.1675	2.3865
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	1000	uM	12365.143	0.0830	-0.2953	2.3865
MCF12A	NM	Basal B	5-DFUR	TYMS	TYMS	5000	uM	12365.143	0.0201	-0.6111	2.3865
MCF7	HR+	Luminal	5-DFUR	TYMS	TYMS	0.0128	uM	10997.143	0.9363	0.8050	0.6416
MCF7	HR+	Luminal	5-DFUR	TYMS	TYMS	0.064	uM	10997.143	0.9669	0.8978	0.6416
MCF7	HR+	Luminal	5-DFUR	TYMS	TYMS	0.32	uM	10997.143	0.9584	0.8717	0.6416
MCF7	HR+	Luminal	5-DFUR	TYMS	TYMS	1.6	uM	10997.143	0.9487	0.8425	0.6416
MCF7	HR+	Luminal	5-DFUR	TYMS	TYMS	8	uM	10997.143	1.0135	1.0423	0.6416
MCF7	HR+	Luminal	5-DFUR	TYMS	TYMS	40	uM	10997.143	0.9200	0.7562	0.6416
MCF7	HR+	Luminal	5-DFUR	TYMS	TYMS	200	uM	10997.143	0.7914	0.3889	0.6416

|<
<<
Previous
Page 118 of 3330
Next
>>
>
2926 to 2950 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)